DR Reddy S Laboratories Limited — Fluoxetine Exporter Profile
Indian Pharmaceutical Exporter · #14 for Fluoxetine · $5.3M export value · DGFT Verified
DR Reddy S Laboratories Limited is the #14 Indian exporter of Fluoxetine with $5.3M in export value and 13 verified shipments. DR Reddy S Laboratories Limited holds a 0.3% market share in Fluoxetine exports across 2 countries. The company exports 50 pharmaceutical products worth $310.6M across 19 therapeutic categories.
DR Reddy S Laboratories Limited — Fluoxetine Export Profile: Buyers & Destinations
Where Does DR Reddy S Laboratories Limited Export Fluoxetine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.1M | 42 | 72.7% |
| UNITED STATES OF AMERICA | $242.9K | 7 | 16.5% |
| UNITED KINGDOM | $125.3K | 3 | 8.5% |
| GERMANY | $18.2K | 2 | 1.2% |
| AUSTRALIA | $15.6K | 1 | 1.1% |
| MALDIVES | $678 | 1 | 0.0% |
DR Reddy S Laboratories Limited exports Fluoxetine to 6 countries. The largest destination is UNITED STATES accounting for 72.7% of DR Reddy S Laboratories Limited's Fluoxetine shipments, followed by UNITED STATES OF AMERICA (16.5%) and UNITED KINGDOM (8.5%). These destinations reflect DR Reddy S Laboratories Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Fluoxetine from DR Reddy S Laboratories Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| DR REDDYS LABORATORIES INC | UNITED STATES | $886.6K | 28 |
| DR REDDY SLABORATORIES INC | UNITED STATES | $226.8K | 8 |
| NORTHSTAR DISTRIBUTION CENTER 8912 | UNITED STATES | $114.8K | 8 |
| MOVIANTO UK LIMITED | UNITED KINGDOM | $88.0K | 2 |
| DR REDDY S LABORATORIES INC | UNITED STATES | $73.5K | 3 |
| MOVIANTO UK LTD | UNITED KINGDOM | $37.3K | 1 |
| NEXT PHARMA LOGISTICS GMBH | GERMANY | $18.2K | 2 |
| DR REDDY S LABORATORIES AUSTRALIA PTY LIMITED | AUSTRALIA | $15.6K | 1 |
| NORTHSTAR DISTRIBUTION CENTER | UNITED STATES | $15.1K | 2 |
| STATE TRADING ORGANIZATION | MALDIVES | $678 | 1 |
DR Reddy S Laboratories Limited supplies Fluoxetine to 10 buyers globally. The largest buyer is DR REDDYS LABORATORIES INC (UNITED STATES), followed by DR REDDY SLABORATORIES INC (UNITED STATES) and NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Fluoxetine Export Value and How Much Does DR Reddy S Laboratories Limited Contribute?
India exported $59.0M worth of Fluoxetine through 3,702 shipments from 253 suppliers to 101 countries, serving 522 buyers globally. DR Reddy S Laboratories Limited contributes $5.3M to this total, accounting for 0.3% of India's Fluoxetine exports. DR Reddy S Laboratories Limited ships Fluoxetine to 6 countries through 10 buyers.
What Is the Average Shipment Value for DR Reddy S Laboratories Limited's Fluoxetine Exports?
DR Reddy S Laboratories Limited's average Fluoxetine shipment value is $410.6K per consignment, based on 13 shipments totaling $5.3M. The largest destination is UNITED STATES (72.7% of DR Reddy S Laboratories Limited's Fluoxetine exports).
How Does DR Reddy S Laboratories Limited Compare to Other Indian Fluoxetine Exporters?
DR Reddy S Laboratories Limited ranks #14 among 253 Indian Fluoxetine exporters with a 0.3% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($10.9M), MICRO LABS LIMITED ($7.7M), ALEMBIC PHARMACEUTICALS LIMITED ($5.8M). DR Reddy S Laboratories Limited processed 13 shipments to 2 destination countries.
What Fluoxetine Formulations Does DR Reddy S Laboratories Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FLUOXETINE TABLETS USP 20MG 33576 X 100S PACKS 3357600 NOS | $50.0K | 1 |
| FLUOXETINE TABLETS USP 20MG 74751 X 100S PACKS=7475100 NOS | $50.0K | 1 |
| FLUOXETINE DELAYED - RELEASE CAPSULES USP 90MG 4 S (8640 PACKS X 4 S = 34560 NOS) | $50.0K | 1 |
| 300026342 FLUOXETINE TABLETS USP 20MG 100S (42480 SU X 100=4248000 NOS) | $50.0K | 1 |
| 300009183 FLUOXETINE DELAYED-RELEASE CAPSULES USP 90MG 4S (18720 SU X 4=74 880 NOS) | $50.0K | 1 |
| FLUOXETINE HARD CAPSULES 60 MG 30 S (28246 X 30 S PACKS = 847380 NOS) | $50.0K | 1 |
| 300026342 FLUOXETINE TABLETS USP 20MG 100S (45528 SU X 100= 4552800 NOS) | $50.0K | 1 |
| FLUOXETINE TABLETS USP 20MG 100S 39480X 100S PACKS=3948000 NOS | $50.0K | 1 |
| FLUOXETINE TABLETS USP 60MG 30S 39240X30S 1177200NOS | $50.0K | 1 |
| FLUOXETINE TABLETS USP 20MG 100S TOTALQTY 64560 X 100S 6456000 NOS | $50.0K | 1 |
DR Reddy S Laboratories Limited exports 56 distinct Fluoxetine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FLUOXETINE TABLETS USP 20MG 33576 X 100S PACKS 3357600 NOS with 1 shipments worth $50.0K.
Regulatory Requirements: Exporting Fluoxetine to Key Markets
What DR Reddy S Laboratories Limited must comply with to export Fluoxetine to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does DR Reddy S Laboratories Limited Compare to Nearest Fluoxetine Exporters?
Exporters ranked immediately above and below #14 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 13 | MEDOPHARM | $1.1M | 21 | 4 | $50.0K |
| 12 | MACLEODS PHARMACEUTICALS LTD | $800.0K | 16 | 5 | $50.0K |
| 14 | DR REDDY S LABORATORIES LIMITED ★ | $650.0K | 13 | 2 | $50.0K |
DR Reddy S Laboratories Limited ranks #14 among 253 Indian Fluoxetine exporters. Average shipment value of $50.0K compared to the market average of $233.1K. The closest competitors by value are MEDOPHARM and MACLEODS PHARMACEUTICALS LTD.
Which Indian Ports Ship Fluoxetine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 603 | 16.3% |
| SAHAR AIR | 508 | 13.7% |
| NHAVA SHEVA SEA (INNSA1) | 285 | 7.7% |
| MUNDRA SEA | 150 | 4.1% |
| MUNDRA SEA (INMUN1) | 129 | 3.5% |
| Bombay Air | 119 | 3.2% |
| DELHI AIR | 110 | 3.0% |
| HYDERABAD ICD (INSNF6) | 108 | 2.9% |
Geopolitical & Trade Policy Impact on DR Reddy S Laboratories Limited's Fluoxetine Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Dr. Reddy's. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.
Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, creating opportunities for Indian exporters. Dr. Reddy's, with its established presence and compliance with stringent regulatory standards, is well-positioned to capitalize on this shift.
In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement. Dr. Reddy's commitment to quality and regulatory adherence ensures its continued access to the EU market, despite the evolving regulatory landscape.
DR Reddy S Laboratories Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for Dr. Reddy's. The company has consistently adhered to FDA, WHO, and EU Good Manufacturing Practices (GMP), ensuring the quality and safety of its products. This commitment is crucial in sustaining trust and credibility in global markets.
However, regulatory challenges persist. In April 2025, Dr. Reddy's received a show cause notice from the Indian Income Tax Department concerning a proposed demand of over ₹2,395 crore related to the merger of Dr. Reddy's Holding Ltd with itself. The company has stated its belief that there is no tax liability arising from the merger and is addressing the matter through appropriate channels. (business-standard.com)
About DR Reddy S Laboratories Limited
DR Reddy S Laboratories Limited exports 50 products worth $310.6M. Beyond Fluoxetine, top products include Metoprolol, Omeprazole, Fexofenadine, Clopidogrel, Esomeprazole. View the complete DR Reddy S Laboratories Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fluoxetine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Fluoxetine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: DR Reddy S Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 56 individual customs records matching DR Reddy S Laboratories Limited exporting Fluoxetine, covering 56 formulations to 6 countries via 10 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 101+ countries, 522+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Fluoxetine Export Data from DR Reddy S Laboratories Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for DR Reddy S Laboratories Limited's Fluoxetine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
DR Reddy S Laboratories Limited
Full Company Profile →
50 products · $310.6M total trade · 19 categories
Fluoxetine Stats
Company Overview
Top Products by DR Reddy S Laboratories Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for DR Reddy S Laboratories Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fluoxetine. For current shipment-level data, contact TransData Nexus.